Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,984.00p on 12-06-2026 at 16:30:00
Change 21.50p 1.1%
Buy 1,981.00p
Sell 1,980.00p
Last Trade: Sell 10,320.00 at 1,984.00p
Day's Volume: 5,538,575
Last Close: 1,984.00p
Open: 1,963.50p
ISIN: GB00BN7SWP63
Day's Range 1,960.00p - 2,011.00p
52wk Range: 1,315.00p - 2,282.00p
Market Capitalisation: £79.54b
VWAP: 1,983.41715p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 10,320 1,984.00p Automatic Execution
16:35:07 - 12-Jun-26
Sell* 7,740 1,984.00p Automatic Execution
16:35:06 - 12-Jun-26
Sell* 2,580 1,984.00p Automatic Execution
16:35:06 - 12-Jun-26
Sell* 2,580 1,984.00p Automatic Execution
16:35:06 - 12-Jun-26
Sell* 5,160 1,984.00p Automatic Execution
16:35:06 - 12-Jun-26
Buy* 2,281 1,984.00p Automatic Execution
16:35:05 - 12-Jun-26
Buy* 501 1,984.00p Automatic Execution
16:35:05 - 12-Jun-26
Buy* 450 1,984.00p Automatic Execution
16:35:05 - 12-Jun-26
Buy* 49 1,984.00p Automatic Execution
16:35:05 - 12-Jun-26
Buy* 200 1,984.00p Automatic Execution
16:35:05 - 12-Jun-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
12th Jun 2026 (Fri) 1,963.50 2,011.00 1,960.00 1,984.00 5,538,575
11th Jun 2026 (Thu) 1,914.00 1,973.00 1,910.50 1,962.50 7,722,952
10th Jun 2026 (Wed) 1,915.50 1,929.00 1,890.50 1,921.50 6,411,067
9th Jun 2026 (Tue) 1,888.00 1,912.00 1,839.00 1,903.50 9,721,895
8th Jun 2026 (Mon) 1,936.50 1,942.50 1,904.50 1,913.00 4,169,869
5th Jun 2026 (Fri) 1,915.50 1,940.00 1,908.00 1,938.00 6,350,731
4th Jun 2026 (Thu) 1,859.50 1,904.00 1,859.00 1,902.00 12,974,263
3rd Jun 2026 (Wed) 1,817.50 1,856.50 1,813.00 1,851.50 8,183,347
2nd Jun 2026 (Tue) 1,840.00 1,842.00 1,805.00 1,820.50 6,580,750
1st Jun 2026 (Mon) 1,866.00 1,882.00 1,832.50 1,842.50 4,511,279
29th May 2026 (Fri) 1,919.50 1,920.50 1,881.50 1,881.50 20,433,488
28th May 2026 (Thu) 1,921.50 1,935.50 1,905.50 1,918.00 6,885,741
27th May 2026 (Wed) 1,893.50 1,943.00 1,893.50 1,939.50 5,898,532
26th May 2026 (Tue) 1,931.50 1,942.50 1,900.00 1,925.00 5,172,404
25th May 2026 (Mon) 1,915.00 1,915.00 1,915.00 1,915.00 0
22nd May 2026 (Fri) 1,925.00 1,927.50 1,906.00 1,915.00 5,933,421
21st May 2026 (Thu) 1,894.00 1,919.00 1,882.00 1,914.50 3,471,573
20th May 2026 (Wed) 1,900.00 1,914.50 1,885.50 1,898.50 4,657,565
19th May 2026 (Tue) 1,879.00 1,909.00 1,872.00 1,902.00 4,650,637
18th May 2026 (Mon) 1,855.50 1,883.00 1,846.00 1,876.50 3,354,365
15th May 2026 (Fri) 1,880.00 1,899.50 1,855.50 1,862.50 11,581,712
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
12th Jun 2026 7:00 am RNS Momelotinib orphan drug designations for VEXAS
11th Jun 2026 3:30 pm RNS Director/PDMR Shareholding
10th Jun 2026 3:30 pm RNS Director/PDMR Shareholding
9th Jun 2026 5:51 pm RNS Dr Hal Barron – New Directorship
9th Jun 2026 7:00 am RNS GSK enters agreement to acquire Nuvalent, Inc.
8th Jun 2026 3:00 pm RNS Transaction in Own Shares
1st Jun 2026 3:00 pm RNS Total Voting Rights
1st Jun 2026 3:00 pm RNS Transaction in Own Shares
28th May 2026 9:30 am RNS Positive Phase 3 data for bepirovirsen
27th May 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK drug momelotinib gains regulatory nods as VEXAS treatment

12th Jun 2026 10:05

(Alliance News) - GSK PLC on Friday announced that momelotinib has received orphan drug designation from the US Food & Drug Administration, and the European Medicines Agency, to treat VEXAS syndrome. Read More

LONDON BRIEFING: UK economy contracts in April; Flutter to leave LSE

12th Jun 2026 07:58

(Alliance News) - The UK economy contracts 0.1% in April, Flutter Entertainment says it will delist from the London Stock Exchange in August, while Alternative Income REIT's largest shareholder makes a takeover bid. Read More

LONDON MARKET MIDDAY: FTSE 100 lags Europe as oil majors, GSK weigh

9th Jun 2026 12:10

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, as the FTSE 100 lagged European peers despite renewed optimism for a peace deal in the Middle East, as oil majors and GSK weighed on the blue-chip index. Read More

WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps

9th Jun 2026 10:34

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON MARKET OPEN: FTSE 100 down as GSK buys US drugmaker Nuvalent

9th Jun 2026 09:09

(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 fell after GSK agreed to buy US-based cancer drug developer Nuvalent for USD10.6 billion. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,471.72
Change167.84

Login to your account

Forgot Password?

Not Registered